Clin2
NCT07259538Possibly a fitRecruiting

Safety study of VVN432 nasal spray

Chronic Rhinosinusitis (CRS)

Part of Ear, nose & throat clinical trials.

This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • For healthy part: you must be in good general health.
  • For sinusitis part: you have had sinus symptoms like stuffy nose, mucus, facial pain, or reduced smell for more than 4 weeks.
  • Your body mass index (BMI) is between 18.5 and 28.0.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You have not taken any investigational drug in the last 12 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06669130Not yet recruiting
Sinus stent for chronic sinusitis trial

This study tests a new sinus stent that slowly releases medicine to treat chronic sinusitis in both nostrils. The goal is to see if it helps reduce symptoms and inflammation better than usual care.

NCT07787494Not yet recruiting
Natural oil nasal spray with reduced steroid for chronic sinusitis

This study tests a nasal spray made from mastic gum oil, combined with a lower dose of a standard steroid nasal spray, to treat chronic sinusitis (long-lasting inflammation of the sinuses). It may help reduce symptoms with fewer side effects from steroids.

Armonia Centro Polispecialistico, Porto Mantovano
NCT06815211Not yet recruiting
Tracking sinusitis control: a German registry study

This study is a registry that tracks how well treatments work for people with chronic rhinosinusitis with nasal polyps. By joining, you help doctors learn which therapies lead to better control and possibly remission of symptoms over time.

NCT07436949Recruiting· Phase 1/Phase 2
Study of BBT002 for chronic sinusitis with nasal polyps and asthma

This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.

Beijing, Beijing Municipality
NCT07313917Not yet recruiting· Phase 2
LP-003 injection for nasal polyps and chronic sinusitis

This trial tests an injection called LP-003 for people with nasal polyps and chronic sinusitis. It aims to reduce symptoms like nasal congestion and improve quality of life. You may qualify if you have tried other treatments and still have symptoms.

Beijing
NCT06372678Not yet recruiting· Phase 2
Testing CM326 for chronic sinusitis with nasal polyps

This study tests a new medicine called CM326 for people with chronic sinusitis and nasal polyps (growths in the nose). It may help if you still have symptoms despite using steroid sprays or if you cannot take steroids.

Beijing, Beijing Municipality

Hear when a new Chronic Rhinosinusitis (CRS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.